Linked Life Data

8458164

Source:http://linkedlifedata.com/resource/pubmed/id/8458164

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-4-28
pubmed:abstractText
Recombinant human erythropoietin administration may prove to be a valuable adjunct in the treatment of the anemia of prematurity. This report provides an overview of fetal and neonatal erythropoiesis, the biology of erythropoietin, and the pathophysiology of the anemia of prematurity. The clinical trials using recombinant human erythropoietin in the treatment of anemia of prematurity are reviewed. Important considerations of this therapy are discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0095-5108
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
169-91
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Erythropoietin therapy for anemia of prematurity.
pubmed:affiliation
Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut.
pubmed:publicationType
Journal Article, Review